Clinical trial · Observational
Study of Tissue Samples From Patients With Glioma or Other Brain Tumors
Identification of Genes Involved in the Pathogenesis of Gliomas by Transcriptome Analysis
NCT00967200CI-TRIAL-00019926completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
RATIONALE: Studying the genes expressed in samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research study is looking at tissue samples from patients with glioma or other brain tumors.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Central Nervous System Lymphoma | Central Nervous System Lymphoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| laboratory biomarker analysis | Other | — | UNRESOLVED |
| pharmacogenomic studies | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Pathophysiology of gliomas
- timeFrame
- 1 day
- description
- Pathophysiology of gliomas that may predict prognosis and progression or that could identify new therapeutic
Secondary outcomes (1)
- measure
- Identification of molecular
- timeFrame
- 1 day
- description
- Identification of molecular markers that may predict prognosis and progression or that could identify new therapeutic
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 120 Years
Show eligibility criteria text
Inclusion Histologically confirmed glioma of any grade or rare primary brain tumor No urgent situation No known or suspected active infection Must not be deprived of liberty or protected by law Not pregnant or nursing Exclusion : No concurrent participation in other trials that require a period of exclusion
References
Publications (0)
Data not yet available
No reference posted for this study.